Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

CA-125 ELIMination Rate Constant K (KELIM) Is a Marker of Chemosensitivity in Patients with Ovarian Cancer: Results from the Phase II CHIVA Trial

PaperCitations, authors & open-access status

CA-125 ELIMination Rate Constant K (KELIM) Is a Marker of Chemosensitivity in Patients with Ovarian Cancer: Results from the Phase II CHIVA Trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 136 citations, 2020 year and closed oa status.

136
Citations
2020
Year
closed
OA Status

Related on ScholarIQ

Pierre Combe
Author
Clinical Cancer Research
Journal
Ovarian cancer diagnosis and treatment
Topic
Ovarian cancer diagnosis and treatment
Topic
Intraperitoneal and Appendiceal Malignancies
Topic
Endometrial and Cervical Cancer Treatments
Topic
470M+ articles · free account